Expression of xenobiotic-metabolizing enzymes in human pulmonary tissue: possible role in susceptibility for ILD
|
|
- Sylvia Quinn
- 5 years ago
- Views:
Transcription
1 Eur Respir J 2001; 18: Suppl. 32, 122s 126s Printed in UK all rights reserved Copyright #ERS Journals Ltd 2001 European Respiratory Journal ISSN ISBN SELECTED REPORT Expression of xenobiotic-metabolizing enzymes in human pulmonary tissue: possible role in susceptibility for ILD J. Hukkanen*, O. Pelkonen*, H. Raunio*,# Expression of xenobiotic-metabolizing enzymes in human pulmonary tissue: possible role in susceptibility for ILD. J. Hukkanen, O. Pelkonen, H. Raunio. #ERS Journals Ltd ABSTRACT: The lung is a major target for all inhaled toxicants. Many inhaled chemicals are not hazardous as such, but are biotransformed to reactive intermediates. Therefore, the pathogenesis of interstitial and other lung diseases is intimately linked to exposure to environmental and other chemicals, which may be causative or modifying factors in the cellular pathways and mechanisms mediating oxidative stress and cell protection in the pulmonary tissue. Several different xenobiotic-metabolizing cytochrome P450 (CYP) and phase II enzymes (i.e. conjugation enzymes including several transferases) are present in the human lung and lung-derived cell lines, possibly contributing to in situ activation and inactivation of chemical toxicants. This paper describes the expression and localization of individual CYP-forms in the lung. Interindividual differences in the expression of these enzymes may contribute to the risk of developing interstitial and other lung diseases initiated by agents that require metabolic activation. Eur Respir J 2001; 18: Suppl. 32, 122s 126s. *Dept of Pharmacology and Toxicology, University of Oulu, Oulu, and # UniversityofKuopio,Kuopio,Finland. Correspondence: O. Pelkonen, Dept of Pharmacology and Toxicology, University of Oulu, POB 5000, FIN Oulu, Finland. Fax: Keywords: Cytochrome P450 cytochrome P450 enzymes xenobiotic-metabolizing enzymes The studies in the authors9 laboratories have been financially supported by the Academy of Finland and the Biomed2 programme (EUROCYP Project). The lung is a major target for all inhaled toxicants. Many chemicals are not hazardous as such, but are biotransformed to reactive intermediates, often by enzymes in the cytochrome P450 (CYP) superfamily [1]. The same chemicals are also detoxified by catalysis via these enzymes. For example, of the several thousands of compounds present in tobacco smoke, several have been found to undergo metabolic activation through xenobiotic-metabolizing CYP enzymes [2, 3]. Enzymes activating or detoxifying environmental chemicals are not the sole factors in the aetiology of chemical-induced lung diseases. Pro-oxidant and antioxidant enzymes and chemicals (many xenobioticmetabolizing enzymes have these same properties), as well as various repair systems, also play an important role in the aetiology or modification of diseases. Their possible role in interstitial lung disease (ILD) induced by exogenous agents is outlined by NEMERY et al. [4] in this Supplement. Metabolic capacity of pulmonary cells A key question concerning organ-specific chemical toxicity is whether the actual target tissue has the capacity to activate (or efficiently inactivate) chemicals [5]. Animal models show that in the case of pulmonary toxicity, several target cells in the lung have the capacity to convert chemicals to reactive forms as well as to detoxify them [6]. Finding evidence for this in humans is more difficult, but various lines of research have established that whole lung tissue, as well as several cell types in the lung, possess metabolic capacity towards numerous xenobiotics [7]. Although the lung contains several enzymatic pathways capable of xenobiotic metabolism, it is generally agreed that the CYP superfamily of enzymes is the main system catalyzing the oxidative metabolism and metabolic activation of most toxicants. However, from the susceptibility point of view, it is equally important to measure variations in phase II detoxifying enzymes (i.e. conjugation enzymes, such as uridine diphosphate (UDP)-glucuronyl transferases and glutathione S-transferases) and pro-oxidant and antioxidant systems, although these areas are less well characterized. It is also notable that, like most of the polycyclic aromatic hydrocarbons (PAH), such as benzo(a)pyrene, the inhaled, highly lipophilic compounds have longer retention times and higher local doses in pulmonary epithelium than less lipophilic compounds, indicating that at least these lipophilic substances are primarily site-of-entry toxicants [6]. Expression of cytochrome P450 forms in human lung For the most recent update on CYP enzymes, consult [8]. The detection of individual CYP forms in human
2 XENOBIOTIC-METABOLIZING ENZYMES IN ILD 123s lung by conventional methods, such as protein purification, catalytic activity studies, and Western immunoblotting, has been difficult due to the low abundance of CYPs in lungs [9]. With the advent of the reverse transcriptase-polymerase chain reaction (RT-PCR) technology it has become possible to detect minute amounts of messenger ribonucleic acid (mrna) in tissue samples. RT-PCR is extremely sensitive and results obtained with it cannot be regarded as a direct indication of the existence of corresponding proteins. Rather, RT-PCR is valuable as a screening method, revealing mrna that can potentially be translated to functional protein in a given tissue. Conversely, absence of mrna in RT- PCR analysis is a strong indication of the lack of a corresponding protein product at biologically meaningful levels. Expression of various CYP enzymes in human lung at mrna and protein level is summarized in table 1. CYP1A1 is by far the most studied human pulmonary CYP [10]. The first report on the expression of CYP1A1 mrna in human lung was by OMIECINSKI et al. [11] in Soon after, the induction of CYP1A1 mrna by tobacco smoking [12], the expression of CYP1A1 protein in human lung [13] and the localization and induction of CYP1A1 protein by tobacco smoke [14] were reported. CYP1A1 protein is only detected in smokers [14] and CYP1A1 expression is positively correlated with aryl hydrocarbon hydroxylase (AHH) activity in human lung tissue [15, 16]. Another PAH-metabolizing CYP, CYP1A2, was detected recently by RT-PCR and Western blot in peripheral lung [17], but earlier reports do not corroborate this finding [13, 18 21]. Also, the presence of CYP1B1 protein in the lung is controversial [22, 23]. CYP1B1 mrna is expressed in human lung [24 26] Table 1. Summary of expression of cytochrome P450s in human lung CYP mrna Protein Comments 1A1 zzz zzz Smokers z/- -- Nonsmokers 1A2 z/- z/- 1B1 zz z/- Protein in alveolar macrophages 2A6 zz z/- 2B6/7 zzz zzz 2C z/- z/- Protein in serous cells of bronchial glands 2D6 z/- z/- 2E1 zzz zzz 2F1 zzz 3A4 z/- z Protein in y20% of cases 3A5 zzz zz 3A7 z/- 4B1 zzz CYP: cytochrome P450; mrna: messenger ribonucleic acid. --: moderate negative evidence; -: weak negative evidence;z/-: conflicting evidence;z: weak positive evidence; zz: moderate positive evidence; zzz: strong positive evidence. and it is inducible by smoking [27]. CYP1B1 is also induced by smoking in alveolar macrophages [28]. CYP2A6 mrna was detected in bronchial epithelium [17, 29], but two reports on the expression of the CYP2A6 protein are contradictory [17, 18]. Studies by the author did not demonstrate CYP2A6 mrna in whole lung tissue homogenate, probably due to dilution of bronchus-specific mrna expression with other cell types of the lung [30]. The expression of pulmonary CYP2A6 protein would be of utmost interest because CYP2A6 has a crucial role in the activation of 4-methylnitrosamino-1,3-pyridyl-1-butanone (NNK), the tobacco-specific procarcinogen [31]. The CYP2B6 gene is expressed in human lung as a splicing variant called CYP2B7 [21, 27, 32] and the corresponding protein is also expressed [17, 33, 34]. A recent immunohistochemistry study suggests a cellspecific expression of CYP2C proteins only in the serous cells of bronchial glands [35]. Out of four previous Western blot studies, two support [19, 36] and two oppose the expression of CYP2C proteins in human lung [37, 38]. CYP2C8 and CYP2C18 mrnas have also been detected in the lung [17]. There has been great interest in studying expression of pulmonary CYP2D6 due to its alleged role in the activation of the tobacco-specific procarcinogen NNK [30]. However, although it is the focus of numerous studies [17, 19, 21, 39 41], the data on the expression of CYP2D6 in human lung is inconsistent. The expression of pulmonary CYP2E1 mrna and protein have been established in several studies [17, 19, 21, 29, 37, 42, 43]. CYP2E1 is an interesting CYP form because it is the most active CYP enzyme in forming oxygen radicals, causing tissue injury [44]. The expression of CYP2F1 has been detected at the mrna level [21, 24, 45], but there are no published results on the expression of CYP2F1 protein. Recombinant CYP2F1 is capable of activating the pulmonary toxicant 3-methylindole [46]. Several studies have demonstrated the expression of CYP3A protein in human lung [17, 19, 20, 37, 47, 48]. The main pulmonary CYP3A form is CYP3A5 [17, 21, 48, 49]. There are no published results on the expression of CYP4B1 protein, but mrna is expressed in human lung [21, 24, 32, 50]. It has been speculated that native human CYP4B1 enzyme is not functional due to inability to incorporate haeme [51]. In conclusion, at least CYPs 1A1 (in smokers), 2B7, 2E1 and 3A5 proteins are expressed in human lung. Other CYP forms are also likely to be expressed, but their expression is probably very low or restricted to specific cell types or individuals. Studies on the expression of certain CYP forms (CYP2F1 and CYP4B1) are still required. Localization of individual cytochrome P450 forms in the lung The cell-specific localization of individual CYP enzymes in the lung is still largely unknown, since there are only a handful of good immunohistochemical studies concerning CYP forms in human lung. It would be of great benefit to the understanding
3 124s J. HUKKANEN ET AL. of cell-specific toxicity to have a comprehensive picture of localization of different CYP forms. The overall distribution of all CYP enzymes can be estimated from the immunohistochemical distribution of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-cytochrome P450 reductase, which is detected in bronchial and bronchiolar epithelium, Clara cells, alveolar lining cells and alveolar macrophages [52]. According to immunohistochemistry, CYP1A1 is mainly expressed at the epithelium of the peripheral airways. CYP1A1 expression does not extend to the epithelium of bronchi w1 mm in diameter and is expressed only in the lungs of smokers [14]. Alveolar macrophages do not express CYP1A1 [14, 28]. Induced CYP1A1 may be a precondition for the development of peripheral lung cancer in smokers, as not a single case of this disease with noninducible CYP1A1 in the lung has been found, and, furthermore, CYP1A1 is localized in the part of the airways in which peripheral cancers arise [14, 53]. A study on the localization of CYP1A1 mrna by in situ hybridization corresponded well with the protein data [54]. Immunohistochemical analysis with CYP3A5- specific antibody shows that CYP3A5 protein is present in all lung samples studied and is localized to the bronchial, bronchiolar and alveolar epithelium, as well as endothelium and alveolar macrophages [49]. Compared with CYP1A1 localization, CYP3A5 expression extends up to larger bronchi. The highest CYP3A5 level is detected in the bronchial lung. Also, CYP3A4 protein is found in some cell types in a minority (y20%) of lung samples with CYP3A4 specific antibody [49]. A few studies with nonspecific CYP3A antibody also show the same pattern of expression as CYP3A5 antibody [47, 48]. CYP2E1 is also localized to human bronchial, bronchiolar and alveolar epithelium, and alveolar macrophages [33, 42, 43]. The localization of the highest expression cannot be evaluated since none of these studies examined both bronchial and peripheral lung. One immunohistochemical report localizes CYP2B7 to human Clara cells [33] and a recent study by YOKOSE et al. [35] observed CYP2C protein in serous cells of bronchial glands, but not in any other cell type of the lung. Surrogate tissues Various surrogate tissues have been used in human biomonitoring studies, the most popular being peripheral blood lymphocytes [55]. Mitogen-treated lymphocytes display inducible CYP1A1 and formation of benzo(a) pyrene-deoxyribonucleic acid (DNA) adducts, and it is suggested that these parameters may correspond with those of the lung tissue in the same individual, although this issue is controversial and still not definitively settled [5, 9]. Alveolar macrophages, which presumably originate from peripheral blood monocytes, have an important role as defence cells against inhaled particles. The expression pattern of CYP genes in alveolar macrophages resembles the pattern found in the whole lung tissue [21]. Thus, alveolar macrophages may provide a model for investigating the relationship between the capacity to activate and detoxify chemicals in an easily accessible lung cell type [28]. In these cells, at least CYP1B1, CYP2E1 and CYP3A5 proteins are expressed, while CYP1A1 is not [15, 28, 42, 49]. Inducibility of cytochrome P450 forms in the lung CYP1A1 is induced by tobacco smoking in human lung, and there is also evidence for the induction of CYP1B1 in smokers [14, 27, 28]. Information about induction of other pulmonary CYP forms in vivo does not exist. However, studies in a continuously growing pulmonary adenocarcinoma cell line (A549) indicate that CYP3A5 is inducible by glucocorticoids [56]. CYP1A1, CYP1B1 and CYP3A5 participate in the activation of PAHs in the tobacco smoke [10, 57, 58] and thus, their induction could have practical significance. Genetic differences in the pulmonary expression of cytochrome P450s The expression of CYP1A1 is regulated by genetic polymorphism and it has been claimed that this hereditary variability contributes to individual susceptibility to environmental chemicals [59]. Although the interindividual variability of CYP3A5 expression in the liver and lung is rather large, several 10-fold, relative contributions of environmental and genetic factors have not been elucidated. "Classical" polymorphic enzymes CYP2D6 and CYP2C19 have not been demonstrated in the human lung. Among phase II enzymes, at least glutathione S-transferase M1 (GSTM1) has been shown to be polymorphic in human lungs and may be associated with differential susceptibility to lung cancer [53, 60]. Conclusions The patterns of constitutive and induced expression of cytochrome P450 forms in several relevant human pulmonary cell types are being unravelled with increasing precision. However, knowledge of the functional activities and cell-specific localization of the pulmonary cytochrome P450 forms is still incomplete, mostly due to sensitivity problems associated with measurements in tissues with a low abundance of cytochrome P450 enzymes. In addition, very little is known about the consequences of interindividual variations in both basal and induced pulmonary cytochrome P450 expression. Reactions catalyzed by cytochrome P450 enzymes are often "leaky", resulting in the transfer of electrons to produce oxygen radicals. Cytochrome P450-catalyzed reactions can thus produce xenobiotic metabolites and oxygen species capable of interfering with cell homeostasis. Thus, the role of xenobiotic metabolism catalyzed by individual pulmonary cytochrome P450 forms in the aetiology of diseases such as interstitial
4 XENOBIOTIC-METABOLIZING ENZYMES IN ILD 125s lung diseases, lung cancer and chronic obstructive pulmonary disease, is still elusive and an intriguing subject for future studies. References 1. Nelson DR, Koymans L, Kamataki T, et al. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 1996; 6: Guengerich FP. Purification and characterization of xenobiotic-metabolizing enzymes from lung tissue. Pharmacol Ther 1990; 45: Gonzalez FJ, Gelboin HV. Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metab Rev 1994; 26: Nemery B, Bast A, Behr J, et al. Interstitial lung disease induced by exogenous agents: factors governing susceptibility. Eur Respir J 2001; 18: Suppl. 32, 30s 42s. 5. Raunio H, Hakkola J, Hukkanen J, et al. Expression of xenobiotic-metabolizing CYPs in human pulmonary tissue. Exp Toxic Pathol 1999; 51: Gerde P, Muggenburg BA, Scott GG, Lewis JL, Pyon KH, Dahl AR. Local metabolism in lung airways increases the uncertainty of pyrene as a biomarker of polycyclic aromatic hydrocarbon exposure. Carcinogenesis 1998; 19: Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999; 91: Nelson D. Cytochrome P450. drnelson.utmem.edu/ nelsonhomepage.html. (Last updated July 3, 2001). 9. Raunio H, Pasanen M, Mäenpää J, Hakkola J, Pelkonen O. Expression of extrahepatic cytochrome P450 in humans. In: Pacifici GM, Fracchia GN, eds. Advances in Drug Metabolism in Man. Luxembourg, European Commission, Office for Official Publications of the European Communities, 1995; pp Shou M, Korzekwa KR, Crespi CL, Gonzalez FJ, Gelboin HV. The role of 12 cdna-expressed human, rodent and rabbit cytochromes P450 in the metabolism of benzo[a]pyrene and benzo[a]pyrene trans-7,8- diol. Mol Carcinog 1994; 10: Omiecinski CJ, Redlich CA, Costa P. Induction and developmental expression of cytochrome P450IA1 messenger RNA in rat and human tissues. Cancer Res 1990; 50: McLemore TL, Adelberg S, Liu MC, et al. Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. J Natl Cancer Inst 1990; 83: Wheeler CW, Park S-S, Guenthner TM. Immunochemical analysis of a cytochrome P-450IA1 homologue in human lung microsomes. Mol Pharmacol 1990; 38: Anttila S, Hietanen E, Vainio H, et al. Smoking and peripheral type of cancer are related to high levels of pulmonary cytochrome P450IA in lung cancer patients. Int J Cancer 1991; 47: Anttila S, Vainio H, Hietanen E, et al. Immunohistochemical detection of pulmonary cytochrome P450IA and metabolic activities associated with P450IA1 and P450IA2 isozymes in lung cancer patients. Environ Health Perspect 1992; 98: Bartsch H, Castegnaro M, Rojas M, Camus A-M, Alexandrov K, Lang M. Expression of pulmonary cytochrome P4501A1 and carcinogen DNA adduct formation in high risk subjects for tobacco-related lung cancer. Toxicol Lett 1992; 64 65: Macé K, Bowman ED, Vautravers P, Shields PG, Harris CC, Pfeifer AMA. Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissue. Eur J Cancer 1998; 34: Shimada T, Yun C-H, Yamazaki H, Gautier J-C, Beaune PH, Guengerich FP. Characterization of human lung microsomal cytochrome P-4501A1 and its role in the oxidation of chemical carcinogens. Mol Pharmacol 1992; 41: Shimada T, Yamazaki H, Mimura M, et al. Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal livers and adult lungs. Drug Metab Dispos 1996; 24: Kelly JD, Eaton DL, Guengerich FP, Coulombe RA. Aflatoxin B 1 activation in human lung. Toxicol Appl Pharmacol 1997; 144: Hukkanen J, Hakkola J, Anttila S, et al. Detection of mrna encoding xenobiotic-metabolizing cytochrome P450s in human bronchoalveolar macrophages and peripheral blood lymphocytes. Mol Carcinog 1997; 20: Murray GI, Taylor MC, McFadyen MCE, et al. Tumor-specific expression of cytochrome P450 CYP1B1. Cancer Res 1997; 57: Tang YM, Chen G-F, Thompson PA, Lin D-X, Lang NP, Kadlubar FF. Development of an antipeptide antibody that binds to the C-terminal region of human CYP1B1. Drug Metab Dispos 1999; 27: Willey JC, Coy E, Brolly C, et al. Xenobiotic metabolism gene expression in human bronchial epithelial and alveolar macrophage cells. Am J Respir Cell Mol Biol 1996; 14: Shimada T, Hayes CL, Yamazaki H, et al. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res 1996; 56: Sutter TR, Tang YM, Hayes CL, et al. Complete cdna sequence of a human dioxin-inducible mrna identifies a new gene subfamily of a cytochrome that maps to chromosome 2. J Biol Chem 1994; 269: Willey JC, Coy EL, Frampton MW, et al. Quantitative RT-PCR measurement of cytochromes p450 1A1, 1B1, and 2B7, microsomal epoxide hydrolase, and NADPH oxidoreductase expression in lung cells of smokers and nonsmokers. Am J Respir Cell Mol Biol 1997; 17: Piipari R, Savela K, Nurminen T, et al. Expression of CYP1A1, CYP1B1 and CYP3A, and polycyclic aromatic hydrocarbon-dna adduct formation in bronchoalveolar macrophages of smokers and nonsmokers. Int J Cancer 2000; 86: Crawford EL, Weaver DA, DeMuth JP, et al. Measurement of cytochrome P450 2A6 and 2E1 gene expression in primary human bronchial epithelial cells. Carcinogenesis 1998; 19: Koskela S, Hakkola J, Hukkanen J, et al. Expression of CYP2A genes in human liver and extrahepatic tissues. Biochem Pharmacol 1999; 57:
5 126s J. HUKKANEN ET AL. 31. Hecht SS. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol 1998; 11: Czerwinski M, McLemore TL, Gelboin HV, Gonzalez FJ. Quantitation of CYP2B7, CYP4B1, and CYPOR messenger RNAs in normal human lung and lung tumors. Cancer Res 1994; 54: Mori M, Tezuka F, Chiba R, et al. Atypical adenomatous hyperplasia and adenocarcinoma of the human lung. Their heterology in form and analogy in immunohistochemical characteristics. Cancer 1996; 77: Gervot L, Rochat B, Gautier JC, et al. Human CYP2B6: expression, inducibility and catalytic activities. Pharmacogenetics 1999; 9: Yokose T, Doy M, Taniguchi T, et al. Immunohistochemical study of cytochrome P450 2C and 3A in human non-neoplastic and neoplastic tissues. Virchows Arch 1999; 434: Nakajima T, Elovaara E, Gonzalez FJ, et al. Styrene metabolism by cdna-expressed human hepatic and pulmonary cytochromes P450. Chem Res Toxicol 1994; 7: Wheeler CW, Wrighton SA, Guenthner TM. Detection of human lung cytochrome P450 that are immunochemically related to cytochrome P450IIE1 and cytochrome P450IIIA. Biochem Pharmacol 1992; 44: Toussaint C, Albin N, Massaad L, et al. Main drugand carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues. Cancer Res 1993; 53: Kivistö KT, Griese E-U, Stuven T, et al. Analysis of CYP2D6 expression in human lung: implications for the association between CYP2D6 activity and susceptibility to lung cancer. Pharmacogenetics 1997; 7: Huang Z, Fasco MJ, Spivack S, Kaminsky LS. Comparisons of CYP2D messenger RNA splice variant profiles in human lung tumors and normal tissues. Cancer Res 1997; 57: Guidice J-ML, Marez D, Sabbagh N, et al. Evidence for CYP2D6 expression in human lung. Biochem Biophys Res Commun 1997; 241: Botto F, Seree E, Khyari SE, et al. Tissue-specific expression and methylation of the human CYP2E1 gene. Biochem Pharmacol 1994; 48: Kivistö KT, Linder A, Friedel G, et al. Immunohistochemical localization of cytochrome P450 2E1 in human pulmonary carcinoma and normal bronchial tissue. Virchows Arch 1995; 426: Ronis MJJ, Lindros KO, Ingelman-Sundberg M, Ioannides C, Parke DV, eds. Cytochromes P450: Metabolic and Toxicological Aspects. 9, The CYP2E subfamily. Boca Raton, CRC Press, 1996; pp Nhamburo PT, Kimura S, McBride OW, Kozak CA, Gelboin HV, Gonzalez FJ. The human CYP2F gene family: identification of a cdna encoding a new cytochrome P450, cdna-directed expression, and chromosome mapping. Biochemistry 1990; 29: Lanza DL, Code E, Crespi CL, Gonzalez FJ, Yost GS. Specific dehydrogenation of 3-methylindole and epoxidation of naphthalene by recombinant human CYP2F1 expressed in lymphoblastoid cells. Drug Metab Dispos 1999; 27: Kivistö KT, Fritz P, Linder A, Friedel G, Beaune P, Kroemer HK. Immunohistochemical localization of cytochrome P450 3A in human pulmonary carcinomas and normal bronchial tissue. Histochemistry 1995; 103: Kivistö KT, Griese E-U, Fritz P, et al. Expression of cytochrome P4503A enzymes in human lung: a combined RT-PCR and immunohistochemical analysis of normal tissue and lung tumors. Naunyn- Schmiedeberg Arch Pharmacol 1996; 353: Anttila S, Hukkanen J, Hakkola J, et al. Expression and localization of CYP3A4 and CYP3A5 in human lung. Am J Respir Cell Mol Biol 1997; 16: Nhamburo PT, Gonzalez FJ, McBride OW, Gelboin HV, Kimura S. Identification of a new P450 expressed in human lung: complete cdna sequence, cdnadirected expression, and chromosome mapping. Biochemistry 1989; 28: Zheng Y-M, Fisher MB, Yokotani N, Fujii-Kuriyama Y, Rettie AE. Identification of a meander region proline residue critical for heme binding to cytochrome P450: implications for the catalytic function of human CYP4B1. Biochemistry 1998; 37: Hall PM, Stupans I, Burgess W, Birkett DJ, McManus ME. Immunohistochemical localization of NADPH-cytochrome P450 reductase in human tissues. Carcinogenesis 1989; 10: Anttila S, Hirvonen A, Husgafvel-Pursiainen K, Karjalainen A, Nurminen T, Vainio H. Combined effect of CYP1A1 inducibility and GSTM1 polymorphism on histological type of lung cancer. Carcinogenesis 1994; 15: Saarikoski ST, Husgafvel-Pursiainen K, Hirvonen A, Vainio H, Gonzalez FJ, Anttila S. Localization of CYP1A1 mrna in human lung by in situ hybridization: comparison with immunohistochemical findings. Int J Cancer 1998; 77: Law MR. Genetic predisposition to cancer. Br J Cancer 1990; 61: Hukkanen J, Lassila A, Päivärinta K, et al. Induction and regulation of xenobiotic-metabolizing cytochrome P450s in the human A549 lung adenocarcinoma cell line. Am J Respir Cell Mol Biol 2000; 22: Roberts-Thomson SJ, McManus ME, Tukey RH, Gonzalez FJ, Holder GM. The catalytic activity of four expressed human cytochromes P450s towards benzo(a)pyrene and the isomers of its proximate carcinogen. Biochem Biophys Res Commun 1993; 3: Kim JH, Stansbury KH, Walker NJ, Trush MA, Strickland PT, Sutter TR. Metabolism of benzo(a)- pyrene and benzo(a)pyrene-7,8-diol by human cytochrome P450 1B1. Carcinogenesis 1998; 19: Hirvonen A. Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer. Environ Health Perspect 1999; 107: Anttila S, Hirvonen A, Vainio H, Husgafvel-Pursiainen K, Hayes JD, Ketterer B. Immunohistochemical localization of glutathione S-transferase in human lung. Cancer Res 1993; 53:
Toxicology 254 (2008) Contents lists available at ScienceDirect. Toxicology. journal homepage:
Toxicology 254 (2008) 1 10 Contents lists available at ScienceDirect Toxicology journal homepage: www.elsevier.com/locate/toxicol Review Critical appraisal of the expression of cytochrome P450 enzymes
More informationTissue-specific Expression and
Metabolic Activation of Toxins: Tissue-specific Expression and Metabolism in Target Organs Olavi Pelkonen and Hannu Raunio Department of Pharmacology and Toxicology, University of Oulu, Oulu, Finland Cytochrome
More informationP450I I E 1 Gene : Dra I. Human Cytochrome Polymorphism and
Tohoku J. Exp. Med., 1992, 168, 113-117 Human Cytochrome Polymorphism and P450I I E 1 Gene : Dra I Susceptibility to Cancer FUMIYUKI VEMATSUHIDEAKI KIKUCHI*, MASAKICHI MOTOMIYA j', TATSUYA ABE j', CHIKASHI
More informationChapter 4. Drug Biotransformation
Chapter 4 Drug Biotransformation Drug Biotransformation 1 Why is drug biotransformation necessary 2 The role of biotransformation in drug disposition 3 Where do drug biotransformation occur 4 The enzymes
More informationMetabolic differences in colon mucosal cells
Metabolic differences in colon mucosal cells Ross A. McKinnon a Wendy M. Burgess a, Frank J. Gonzalez b and Michael E. McManus c a Department of Clinical Pharmacology, Flinders University, South Australia
More informationB. Incorrect! Compounds are made more polar, to increase their excretion.
Pharmacology - Problem Drill 04: Biotransformation Question No. 1 of 10 Instructions: (1) Read the problem and answer choices carefully, (2) Work the problems on paper as 1. What is biotransformation?
More informationChapter 9. Biotransformation
Chapter 9 Biotransformation Biotransformation The term biotransformation is the sum of all chemical processes of the body that modify endogenous or exogenous chemicals. Focus areas of toxicokinetics: Biotransformation
More informationCysteine Peptide Scientific Review, Dr. S. Dudek, DMV International
Cysteine Peptide Scientific Review, Dr. S. Dudek, DMV International Ethanol and Glutathione Reduced glutathione plays a critical role in cellular detoxification processes including the metabolism of peroxides,
More informationOpinion on. Classification of Musk ketone
EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL Directorate C - Public Health and Risk Assessment C7 - Risk assessment SCIENTIFIC COMMITTEE ON HEALTH AND ENVIRONMENTAL RISKS SCHER
More informationBMC Gastroenterology. Open Access. Abstract
BMC Gastroenterology BioMed Central Research article Decreased expression of cytochrome P450 protein in non-malignant colonic tissue of patients with colonic adenoma Ina Bergheim* 1,2, Christiane Bode
More informationTSUTOMU SHIMADA, YOSHIMITSU ODA, ELIZABETH M. J. GILLAM, F. PETER GUENGERICH, AND KIYOSHI INOUE
0090-9556/01/2909-1176 1182$3.00 DRUG METABOLISM AND DISPOSITION Vol. 29, No. 9 Copyright 2001 by The American Society for Pharmacology and Experimental Therapeutics 403/923026 DMD 29:1176 1182, 2001 Printed
More informationAssociation between the CYP1A1 polymorphisms and hepatocellular carcinoma: a meta-analysis
Association between the CYP1A1 polymorphisms and hepatocellular carcinoma: a meta-analysis B.W. Yu 1 *, L.Q. Zhang 1 *, X.L. Teng 1, Y. Zhang 1, L.B. Zou 2 and H.Y. Ying 3 l Department of Clinical Laboratory,
More informationExpression of Xenobiotic Metabolizing Enzymes in Different Lung Compartments of Smokers and Nonsmokers
Research Expression of Xenobiotic Metabolizing Enzymes in Different Lung Compartments of Smokers and Nonsmokers Thomas Thum, 1,2* Veit J. Erpenbeck, 3* Julia Moeller, 1,3 Jens M. Hohlfeld, 3 Norbert Krug,
More informationReal-Time Polymerase Chain Reaction Analysis of CYP1B1 Gene Expression in Human Liver
TOXICOLOGICAL SCIENCES 71, 11 19 (2003) Copyright 2003 by the Society of Toxicology Real-Time Polymerase Chain Reaction Analysis of CYP1B1 Gene Expression in Human Liver Thomas K. H. Chang, 1 Jie Chen,
More informationGenomics and proteomics offers new hopes towards a personalized approach to lung cancer prevention and treatment
Electronic Journal of Biotechnology ISSN: 0717-3458 Vol.6 No.3, Issue of December 15, 2003 2003 by Pontificia Universidad Católica de Valparaíso -- Chile BIOTECHNOLOGY ISSUES FOR DEVELOPING COUNTRIES Genomics
More informationPHYSIOLOGY AND MAINTENANCE Vol. II Biotransformation of Xenobiotics and Hormones - Osmo Hanninen BIOTRANSFORMATION OF XENOBIOTICS AND HORMONES
BIOTRANSFORMATION OF XENOBIOTICS AND HORMONES Osmo Hänninen Department of Physiology, University of Kuopio, Finland Keywords: foreign compounds, xenobiotics, bioactivation, detoxification, oxidation, cytochrome
More informationCytochrome P 450 Unique family of heme proteins present in bacteria, fungi, insects, plants, fish, mammals and primates. Universal oxygenases (oxygen-
Cytochrome P 450 Biochemistry Department Cytochrome P 450 Unique family of heme proteins present in bacteria, fungi, insects, plants, fish, mammals and primates. Universal oxygenases (oxygen-utilizing
More informationoptimal health for life genotype report Name: Date of Birth: Sample Number: Referring Practitioner: Date Reported:
optimal health for life genotype report Name: Date of Birth: Sample Number: Referring Practitioner: Date Reported: DNA Oestrogen - Genotype Report Page No. 2 of 9 Welcome to your dna oestrogen report From
More informationBIOMARKERS AND TOXICITY MECHANISMS 07 Mechanisms Metabolism & Detoxification. Luděk Bláha, PřF MU, RECETOX
BIOMARKERS AND TOXICITY MECHANISMS 07 Mechanisms Metabolism & Detoxification Luděk Bláha, PřF MU, RECETOX www.recetox.cz Metabolism and detoxification Chemicals enter body... mostly via food Pass directly
More informationEnvironmental Management & Pollution Environmental and Chemical Carcinogenesis
Environmental Management & Pollution Environmental and Chemical Carcinogenesis 8.1 Abstract People are continuously exposed exogenously to varying amounts of chemicals that have been shown to have carcinogenic
More informationChemical Carcinogenesis November
Chemical Carcinogenesis November 18 2014 Cancer Incidence and Death rates by Geography Epidemiological studies of cancer incidence indicate: 1. The incidence rates for specific organ tumors varies among
More informationChemical Carcinogenesis November
Chemical Carcinogenesis November 17 2016 Cancer Incidence and Death rates by Geography Epidemiological studies of cancer incidence indicate: 1. The incidence rates for specific organ tumors varies among
More informationCIGARETTE SMOKING remains one of the leading
Role of CYP2A6 Genetic Variation on Smoking Behaviors and Clinical Implications By Man Ki Ho, Hon BSc, and Rachel F. Tyndale, PhD Overview: Cigarette smoking is responsible for numerous health problems,
More informationaccesalabs.c
Patient: DOB: Sex: F MRN: JANE DOE (CYP1A1) detoxifies polycyclic aromatic hydrocarbons (PAHs) produced from the combustion of organic materials (exhaust fumes, charbroiled meats, etc.). (CYP1B1) is involved
More informationGenetics and Genomics: Influence on Individualization of Medication Regimes
Genetics and Genomics: Influence on Individualization of Medication Regimes Joseph S Bertino Jr., Pharm.D., FCCP Schenectady, NY USA Goals and Objectives To discuss pharmacogenetics and pharmacogenomics
More informationIn Situ Hybridization and Immunohistochemical Analysis of Cytochrome P450 1B1 Expression in Human Normal Tissues
Volume 49(2): 229 236, 2001 The Journal of Histochemistry & Cytochemistry http://www.jhc.org ARTICLE In Situ Hybridization and Immunohistochemical Analysis of Cytochrome P450 1B1 Expression in Human Normal
More informationPHASE I Detoxification: The First Line of Defense
Sex DOB TM DetoxiGenomic Profile PHASE I Detoxification: The First Line of Defense In Phase I detoxification, enzymes, known collectively as the cytochrome P-450 system, use oxygen to modify toxic compounds,
More informationWelcome. to your dna osetrogen report. Welcome to your dna oestrogen report
optimal health for life Welcome to your dna osetrogen report Date of Birth: Date Reported: Sample Number: Referring Practitioner: Welcome to your dna oestrogen report From your buccal swab sample we have
More informationSimultaneous, rapid and sensitive quantification of 8-hydroxy-2'-deoxyguanosine and cotinine in human urine
Analytical and Bioanalytical Chemistry Electronic Supplementary Material Simultaneous, rapid and sensitive quantification of 8-hydroxy-2'-deoxyguanosine and cotinine in human urine by on-line solid-phase
More informationdna oestrogen GENOTYPE REPORT Patient Name: Date of Birth: Sample Number: Referring Practitioner: Date Reported:
dna oestrogen GENOTYPE REPORT Patient Name: Date of Birth: Sample Number: Referring Practitioner: Date Reported: BACKGROUND TO THE ANALYSIS The importance of both oestrogen and progesterone in breast cancer
More information2. List routes of exposure in the order of most rapid response.
Practice Test questions: 1. What are the two areas of toxicology that a regulatory toxicologist must integrate in order to determine the "safety" of any chemical? 2. List routes of exposure in the order
More informationEstrogen Report GENOTYPE REPORT OPTIMAL HEALTH FOR LIFE. John Doe NAME DATE OF BIRTH 7/31/1999 REFFERRING PRACTITIONER. Dr. Exercise/Diet specialist
Estrogen Report OPTIMAL HEALTH FOR LIFE NAME John Doe DATE OF BIRTH 7/31/1999 GENOTYPE REPORT REFFERRING PRACTITIONER DATE REPORTED ACCESSION NUMBER Dr. Exercise/Diet specialist 2/27/2018 8:42:57 AM 000000000001
More informationVariability Due to Genetic Differences
1 Variability Due to Genetic Differences Nick Holford Dept Pharmacology & Clinical Pharmacology University of Auckland 2 Objectives Understand how between individual variation may contribute to :» drug
More informationPolymorphisms of CYP2A6 and its practical consequences
Review Series on Pharmacogenomics edited by Prof. M. Pirmohamed Polymorphisms of CYP2A6 and its practical consequences annu Raunio 1, Arja Rautio 2, arriet GullsteÂn 2 & Olavi Pelkonen 2 1 Department of
More informationEffects of Pregnancy, Age and Sex in the Metabolism of Styrene in Rat Liver in Relation to the Regulation of Cytochrome P450 Enzymes
J Occup Health 2005; 47: 49 55 Journal of Occupational Health Effects of Pregnancy, Age and Sex in the Metabolism of Styrene in Rat Liver in Relation to the Regulation of Cytochrome P450 Enzymes Reiko
More informationConstitutive Regulation of P450s by Endocrine Factors
References: Constitutive Regulation of P450s by Endocrine Factors Meyer UA. Endo-xenobiotic crosstalk and the regulation of cytochromes P450. Drug Metab Rev 39:639-46, 2007. Waxman DJ and O Connor C. Growth
More informationA Regional Model of Lung Metabolism for Improving Species Dependent Descriptions of 1,3-Butadiene and its Metabolites
A Regional Model of Lung Metabolism for Improving Species Dependent Descriptions of 1,3-Butadiene and its Metabolites Harvey Clewell, Jerry Campbell, and Cynthia VanLandingham ENVIRON and The Hamner Institutes
More informationSmoke Like a Man, Survive Like a Woman
Smoke Like a Man, Survive Like a Woman Sex Specific Differences in Lung Cancer Pulmonary Grand Rounds Philippe R. Montgrain, M.D. May 1, 2008 Objectives 1. Review how lung cancer differs in men and women.
More informationINVOLVEMENT OF CYP2E1 AS A LOW-AFFINITY ENZYME IN PHENACETIN O-DEETHYLATION IN HUMAN LIVER MICROSOMES
0090-9556/99/2708-0860 865$02.00/0 DRUG METABOLISM AND DISPOSITION Vol. 27, No. 8 Copyright 1999 by The American Society for Pharmacology and Experimental Therapeutics Printed in U.S.A. INVOLVEMENT OF
More informationVARIABLE CYP2A6-MEDIATED NICOTINE METABOLISM ALTERS SMOKING BEHAVIOR AND RISK
0090-9556/01/2904-548 552$3.00 DRUG METABOLISM AND DISPOSITION Vol. 29, No. 4, Part 2 Copyright 2001 by The American Society for Pharmacology and Experimental Therapeutics 290118/894071 DMD 29:548 552,
More informationMechanism of Detoxification
Mechanism of Detoxification Prof.Dr. Hedef Dhafir El-Yassin 1 Objectives: 1. To list the detoxification pathways 2. To describe detoxification pathways and phases in the liver, 2 3 4 o Xenobiotics are
More informationMechanistic Toxicology
SECOND EDITION Mechanistic Toxicology The Molecular Basis of How Chemicals Disrupt Biological Targets URS A. BOELSTERLI CRC Press Tavlor & France Croup CRC Press is an imp^t o* :H Taylor H Francn C'r,,jpi
More informationCYP2A13 in Human Respiratory Tissues and Lung Cancers: An Immunohistochemical Study with A New Peptide-Specific Antibody
0090-9556/06/3410-1672 1676$20.00 DRUG METABOLISM AND DISPOSITION Vol. 34, No. 10 Copyright 2006 by The American Society for Pharmacology and Experimental Therapeutics 11049/3137941 DMD 34:1672 1676, 2006
More informationA. Incorrect! The alveolus is where gas exchange takes place. B. Correct! Surfactant is the lipid-rich material that permits lung inflation.
Toxicology - Problem Drill 13: Respiratory Toxicology No. 1 of 10 1. The lipid-rich material that decreases surface tension of the alveoli, allowing sacs to inflate properly and remain inflated during
More informationWelcome to your dna oestrogen report
optimal health for life Welcome Report Sample to your dna oestrogen report Date of Birth: 08 Jan 1990 Date Reported: 31 May 2018 05:33 Sample Number: DNA000000ZA Referring Practitioner: Doctor X Welcome
More informationXenobiotic metabolising enzyme expression in
1234 Department of Pathology J A McKay SW B Ewen G I Murray Department of Biomedical Sciences R J Weaver M D Burke Department of Molecular and Cell Biology, University of Aberdeen, Aberdeen W T Melvin
More informationCATALYTIC SPECIFICITY OF CYP2D ISOFORMS IN RAT AND HUMAN
0090-9556/02/3009-970 976$7.00 DRUG METABOLISM AND DISPOSITION Vol. 30, No. 9 Copyright 2002 by The American Society for Pharmacology and Experimental Therapeutics 696/1004051 DMD 30:970 976, 2002 Printed
More informationDepartment of Respiratory Medicine, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, China
Association of glutathione S-transferase (GST) genetic polymorphisms with treatment outcome of cisplatin-based chemotherapy for advanced non-small cell lung cancer in a Chinese population H.L. Xiao 1,
More informationAssociation of CYP2A6 Gene Deletion with Cigarette Smoking Status in Japanese Adults
Journal of Epidemiology Vol. 13, No. 3 May 2003 Original Article Association of CYP2A6 Gene Deletion with Cigarette Smoking Status in Japanese Adults Masahiko Ando,1 Nobuyuki Hamajima,2 Noritaka Ariyoshi,3
More informationP450 CYCLE. All P450s follow the same catalytic cycle of;
P450 CYCLE All P450s follow the same catalytic cycle of; 1. Initial substrate binding 2. First electron reduction 3. Oxygen binding 4. Second electron transfer 5 and 6. Proton transfer/dioxygen cleavage
More informationKing s Research Portal
King s Research Portal DOI: 10.1002/em.22001 Document Version Publisher's PDF, also known as Version of record Link to publication record in King's Research Portal Citation for published version (APA):
More informationBIOCHEMISTRY and MOLECULAR BIOLOGY INTERNATIONAL DIFFERENTIAL INHIBITION OF AFLATOXIN B1 OXIDATION BY GESTODENE ACTION ON HUMAN LIVER MICROSOMES
Vol. 43, No. 4, November 1997 Pages 839-846 DIFFERENTIAL INHIBITION OF AFLATOXIN B1 OXIDATION BY GESTODENE ACTION ON HUMAN LIVER MICROSOMES Bok Ryang Kim,* Hyun Sook Oh,** and Dong-Hyun Kim ~t'l *Department
More informationA DISSERTATION SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY OF MINNESOTA BY. Yan Zhong
Phenanthrene Tetraols as Probes for the Metabolic Activation of Carcinogenic Polycyclic Aromatic Hydrocarbons in Humans A DISSERTATION SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY
More informationCOEXPRESSION OF CYTOCHROME P4502A6 AND HUMAN NADPH-P450 OXIDOREDUCTASE IN THE BACULOVIRUS SYSTEM
0090-9556/97/2504-0399 405$02.00/0 DRUG METABOLISM AND DISPOSITION Vol. 25, No. 4 Copyright 1997 by The American Society for Pharmacology and Experimental Therapeutics Printed in U.S.A. COEXPRESSION OF
More informationDevelopment of important genes during breast carcinogenesis
Nagoya Med. J., 107 Development of important genes during breast carcinogenesis AYA NAIKI-ITO Department of experimental pathology and tumor biology Nagoya City University Graduate School of Medical Sciences
More informationAssociation between ERCC1 and ERCC2 polymorphisms and breast cancer risk in a Chinese population
Association between ERCC1 and ERCC2 polymorphisms and breast cancer risk in a Chinese population R. Zhao and M.F. Ying Department of Pharmacy, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University,
More informationENHANCEMENT OF CYTOCHROME P-450 3A4 CATALYTIC ACTIVITIES BY CYTOCHROME b 5 IN BACTERIAL MEMBRANES
0090-9556/99/2709-0999 1004$02.00/0 DRUG METABOLISM AND DISPOSITION Vol. 27, No. 9 Copyright 1999 by The American Society for Pharmacology and Experimental Therapeutics Printed in U.S.A. ENHANCEMENT OF
More informationThe role of metabolic inhibition-interactions on toxicity
Muhammad Umer Naeem M.Sc. Thesis Master s Degree Programme in General Toxicology and Environmental Health Risk Assessment Faculty of Health Sciences University of Eastern Finland Dated 23.06.2014 Supervisors:
More informationCYP1A1, GSTM1 and NQO1 gene polymorphisms: Genetic risk factors for small cell lung cancer
Turkish Journal of Cancer Volume 35, No.4, 2005 171 CYP1A1, GSTM1 and NQO1 gene polymorphisms: Genetic risk factors for small cell lung cancer AYÞE DEM RKAN 1, BURÇAK VURAL 1, ZEK ÜSTÜNER 2, KAZIM UYGUN
More informationROLES OF HUMAN CYP2A6 AND 2B6 AND RAT CYP2C11 AND 2B1 IN THE 10-HYDROXYLATION OF ( )-VERBENONE BY LIVER MICROSOMES
0090-9556/03/3108-1049 1053$7.00 DRUG METABOLISM AND DISPOSITION Vol. 31, No. 8 Copyright 2003 by The American Society for Pharmacology and Experimental Therapeutics 1076/1078953 DMD 31:1049 1053, 2003
More informationGSTM1, smoking and lung cancer: a case-control study
International Epidemiological Association 1999 Printed in Great Britain International Journal of Epidemiology 1999;28:829 835 GSTM1, smoking and lung cancer: a case-control study I Stücker, a I de Waziers,
More informationCytokrom P450 (CYP) Hepatic Drug Metabolism. Medicines in plasma. Plasma concentration of a medicine. Eva Brittebo Dept Pharmaceutical Biosciences
Hepatic Drug Metabolism Eva Brittebo Dept Pharmaceutical Biosciences Background Cytochrome P450 (CYP) Liver metabolism Liver toxicity Inhibition and induction Polymorphism 15-05-13 2 Plasma concentration
More informationGENETIC POLYMORPHISMS AND THE RISK OF LUNG CANCER IN TUNNEL WORKERS IN RIO DE JANEIRO, BRAZIL
Air Pollution XXV 63 GENETIC POLYMORPHISMS AND THE RISK OF LUNG CANCER IN TUNNEL WORKERS IN RIO DE JANEIRO, BRAZIL CLAUDIA R. RAINHO 1, ÉRIKA MORAES 1, ANDRÉ LUIZ MENCALHA 2 & ISRAEL FELZENSZWALB 1 1 Laboratório
More information4. Other Data Relevant to an Evaluation of Carcinogenicity and its Mechanisms
512 IARC MONOGRAPHS VOLUME 92 4. Other Data Relevant to an Evaluation of Carcinogenicity and its Mechanisms 4.1 Toxicokinetics 4.1.1 Absorption, distribution, metabolism and excretion (a) Overview This
More informationINVESTIGATION OF THE BIOTRANSFORMATION OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE BY PROSTAGLANDIN H SYNTHASE AND CYTOCHROME P450 2F
INVESTIGATION OF THE BIOTRANSFORMATION OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE BY PROSTAGLANDIN H SYNTHASE AND CYTOCHROME P450 2F by Hana M. Fikree A thesis submitted to the Department of Pharmacology
More informationCYP1A1 and CYP1B1 Polymorphism and Lung Cancer Risk in Relation to Tobacco Smoking
CYP1A1 and CYP1B1 Polymorphism and Lung Cancer Risk in Relation to Tobacco Smoking JOACHIM SCHNEIDER, ULRIKE BERNGES*, MONIKA PHILIPP and HANS-JOACHIM WOITOWITZ Institut und Poliklinik für Arbeits- und
More informationIt the process by which a drug reversibly leaves blood and enter interstitium (extracellular fluid) and/ or cells of tissues.
It the process by which a drug reversibly leaves blood and enter interstitium (extracellular fluid) and/ or cells of tissues. Primarily depends on: 1.Regional blood flow. 2.Capillary permeability. 3.Protein
More informationScientific Evidence for Evaluating Modified Risk Tobacco Products
Scientific Evidence for Evaluating Modified Risk Tobacco Products Presented to the IOM Committee on Scientific Standards for Modified Risk Tobacco Products May 9 th 2011, Washington DC 1 l Altria Client
More informationDrug Metabolism Phase 2 conjugation reactions. Medicinal chemistry 3 rd stage
Drug Metabolism Phase 2 conjugation reactions Medicinal chemistry 3 rd stage 1 Phase II or Conjugation reactions 1. Glucuronic acid conjugation 2. Sulfate conjugation 3. Glycine and Glutamine conjugation
More informationMetabolic Changes of Drugs and Related Organic Compounds
Metabolic Changes of Drugs and Related Organic Compounds 3 rd stage/ 1 st course Lecture 3 Shokhan J. Hamid 2 Metabolism plays a central role in the elimination of drugs and other foreign compounds from
More informationMODULE No.26: Drug Metabolism
SUBJECT Paper No. and Title Module No. and Title Module Tag PAPER No. 9: Drugs of Abuse MODULE No. 26: Drug Metabolism FSC_P9_M26 TABLE OF CONTENTS 1. Learning Outcomes 2. Introduction 3. Sites of Drug
More informationToxicant Disposition and Metabolism. Jan Chambers Center for Environmental Health Sciences College of Veterinary Medicine
Toxicant Disposition and Metabolism Jan Chambers Center for Environmental Health Sciences College of Veterinary Medicine chambers@cvm.msstate.edu Definitions Disposition Absorption passage across membrane.
More informationPharmacology & Therapeutics
Pharmacology & Therapeutics 118 (2008) 250 267 Contents lists available at ScienceDirect Pharmacology & Therapeutics journal homepage: www.elsevier.com/locate/pharmthera The ontogeny of drug metabolism
More informationHuman Lung Cancer Pathology and Cellular Biology Mouse Lung Tumor Workshop
Human Lung Cancer Pathology and Cellular Biology Mouse Lung Tumor Workshop Jan 7 th and 8 th, 2014 Brigitte Gomperts, MD University of California, Los Angeles Lung Structure and Function Airway Epithelial
More informationCytochrome P450 (CYP) enzymes are a superfamily of
Expression of Cytochrome P450 (CYP) Enzymes in Human Nonpigmented Ciliary Epithelial Cells: Induction of CYP1B1 Expression by TCDD Marjo Volotinen, 1,2 Jukka Mäenpää, 2 Esko Kankuri, 1 Olli Oksala, 2 Olavi
More informationMolecular docking of retinoic acid with cytochrome P450 isoforms CYP1A1, 1A2 and 1B1 a potential drug target against carcinogen benzo(a)pyrene
World Journal of Pharmaceutical Sciences ISSN (Print): 2321-3310; ISSN (Online): 2321-3086 Published by Atom and Cell Publishers All Rights Reserved Available online at: http://www.wjpsonline.org/ Original
More informationAn overview on the allelic variant of CYP2D6 genotype
African Journal of Biotechnology Vol. 9 (54), pp. 9096-9102, 29 December, 2010 Available online at http://www.academicjournals.org/ajb ISSN 1684 5315 2010 Academic Journals Review An overview on the allelic
More informationScience that studies adverse skin effects and the substances that produce them
Science that studies adverse skin effects and the substances that produce them Leena A. Nylander-French, Ph.D., CIH 159 Rosenau Tel: 966.3826 E-mail: leena_french@unc.edu Occupational skin diseases are
More information6 Literaturverzeichnis
6 Literaturverzeichnis 1. Abdelaziz MM, Devalia JL, Khair OA, Calderon M, Sapsford RJ, Davies RJ: The effect of conditioned medium from cultured human bronchial epithelial cells on eosinophil and neutrophil
More informationSupplemental Information
Supplemental Information Tobacco-specific Carcinogen Induces DNA Methyltransferases 1 Accumulation through AKT/GSK3β/βTrCP/hnRNP-U in Mice and Lung Cancer patients Ruo-Kai Lin, 1 Yi-Shuan Hsieh, 2 Pinpin
More informationCYP2A13 in Human Respiratory Tissues and Lung Cancers: An. Immunohistochemical Study with A New Peptide-specific Antibody
DMD Fast This article Forward. has not been Published copyedited on and June formatted. 30, The 2006 final version as doi:10.1124/dmd.106.011049 may differ from this version. CYP2A13 in Human Respiratory
More informationExposure and Kinetics of Polycyclic Aromatic Hydrocarbons (PAHs) in Cigarette Smokers
pubs.acs.org/crt Exposure and Kinetics of Polycyclic Aromatic Hydrocarbons (PAHs) in Cigarette Smokers Gideon St.Helen, Maciej L. Goniewicz, Delia Dempsey, Margaret Wilson, Peyton Jacob, III, and Neal
More informationSusceptibility towards formaldehyde-induced genotoxicity. Günter Speit
Susceptibility towards formaldehyde-induced genotoxicity Günter Speit Universität Ulm Institut für Humangenetik D-89069 Ulm (Germany) guenter.speit@uni-ulm.de CEFIC-2012 Günter Speit 1 Susceptibility towards
More informationThe use of biomarkers and genetic epidemiology
The use of biomarkers and genetic epidemiology Alan R Boobis Imperial College London a.boobis@imperial.ac.uk Understanding Epidemiology for Chemical Risk Assessment 6-8 October, 2010, Cranfield Biomarkers
More informationRESEARCH ARTICLE. Ufuk Berber 1 *, Ismail Yilmaz 1, Omer Yilmaz 2, Aptullah Haholu 1, Zafer Kucukodaci 1, Ferhat Ates 2, Dilaver Demirel 1.
DOI:http://dx.doi.org/0.734/APJCP.203.4.6.3925 RESEARCH ARTICLE CYPA (Ile 462 Val), CYPB (Ala 9 Ser and Val 432 Leu), GSTM (null), and GSTT (null) Polymorphisms and Bladder Cancer Risk in a Turkish Population
More information! These tests are not 100% accurate! Positive findings indicates predisposition only.! Results should not be interpreted as diagnostic with treatment
INTERPRETATION ! These tests are not 100% accurate! Positive findings indicates predisposition only.! Results should not be interpreted as diagnostic with treatment recommendations. ! Normal gene (-)
More informationShoba Iyer, Frederica Perera, Bingzhi Zhang 1, Stephen Chanock 2, Shuang Wang 1 and Deliang Tang*
Carcinogenesis vol.35 no.1 pp.69 75, 2014 doi:10.1093/carcin/bgt339 Advance Access publication October 31, 2013 Significant interactions between maternal AH exposure and s in candidate genes on B[a]-DNA
More informationFUNCTIONAL CHARACTERIZATION OF CYTOCHROME P450 2B6 ALLELIC VARIANTS
0090-9556/03/3104-398 403$7.00 DRUG METABOLISM AND DISPOSITION Vol. 31, No. 4 Copyright 2003 by The American Society for Pharmacology and Experimental Therapeutics 973/1050100 DMD 31:398 403, 2003 Printed
More informationCourse Title Form Hours subject
Course Title Form Hours subject Types, and structure of chromosomes L 1 Histology Karyotyping and staining of human chromosomes L 2 Histology Chromosomal anomalies L 2 Histology Sex chromosomes L 1 Histology
More informationExpression of Xenobiotic Metabolizing Genes in Head and Neck Cancer Tissues
Expression of Xenobiotic Metabolizing Genes in Head and Neck Cancer Tissues RESEARCH COMMUNICATION Expression of Xenobiotic Metabolizing Genes in Head and Neck Cancer Tissues Nosheen Masood, Fraz Arshad
More informationEivor Elovaara Jouni Mikkola Helene Stockmann-Juvala Leena Luukkanen Helena Keski-Hynnilä Risto Kostiainen Markku Pasanen Olavi Pelkonen Harri Vainio
Arch Toxicol (2007) 81:169 182 DOI 10.1007/s00204-006-0135-8 METABOLIC ACTIVATION/INACTIVATION Polycyclic aromatic hydrocarbon (PAH) metabolizing enzyme activities in human lung, and their inducibility
More informationHypertrophy of cardiac muscle in the left ventricular chamber.
The increase in the size of cells and consequently in the size of the affected organ. caused by specific hormone stimulation or by increased functional demand. ü ü Pregnancy: an adaptive response muscular
More informationExtensive protein interactions involving cytochrome P450 3A4: a possible contributor to the formation of a metabolosome
ORIGINAL ARTICLE Extensive protein interactions involving cytochrome P450 3A4: a possible contributor to the formation of a metabolosome Ryoichi Fujiwara & Tomoo Itoh School of Pharmacy, Kitasato University,
More informationEarly Life Development of Toxicokinetic Pathways: Framework Case Examples and Implications for Safety Assessment
Early Life Development of Toxicokinetic Pathways: Framework Case Examples and Implications for Safety Assessment Gary Ginsberg Connecticut Department of Public Health Conflict of Interest Statement Some
More informationMEDCHEM 570. First Midterm. January 30, 2015
Name MEDCHEM 570 First Midterm January 30, 2015 Instructions: Exam packet totals 7 pages. The last page has a 5 points extra credit question. If you need additional space for a question go to the back
More informationMETABOLISM OF ( )- AND ( )-LIMONENES TO RESPECTIVE CARVEOLS AND PERILLYL ALCOHOLS BY CYP2C9 AND CYP2C19 IN HUMAN LIVER MICROSOMES
0090-9556/02/3005-602 607$7.00 DRUG METABOLISM AND DISPOSITION Vol. 30, No. 5 Copyright 2002 by The American Society for Pharmacology and Experimental Therapeutics 641/981193 DMD 30:602 607, 2002 Printed
More informationREGULATION OF CYTOCHROME P4501A1 EXPRESSION IN RAT SMALL INTESTINE
0090-9556/97/2501-0021 26$02.00/0 DRUG METABOLISM AND DISPOSITION Vol. 25, No. 1 Copyright 1997 by The American Society for Pharmacology and Experimental Therapeutics Printed in U.S.A. REGULATION OF CYTOCHROME
More informationMembrane Fluidity Changes Are Associated with Benzo[a]Pyrene-Induced Apoptosis in F258 Cells
Membrane Fluidity Changes Are Associated with Benzo[a]Pyrene-Induced Apoptosis in F258 Cells Protection by Exogenous Cholesterol MORGANE GORRIA, a XAVIER TEKPLI, a ODILE SERGENT, b LAURENCE HUC, a FRANÇOIS
More informationREVIEW. Tobacco Smoke Carcinogens and Lung Cancer. Stephen S. Hecht
REVIEW Tobacco Smoke Carcinogens and Lung Cancer Stephen S. Hecht The complexity of tobacco smoke leads to some confusion about the mechanisms by which it causes lung cancer. Among the multiple components
More informationChapter 6: Estrogen Metabolism by Conjugation
Chapter 6: Estrogen Metabolism by Conjugation Rebecca Raftogianis, Cyrus Creveling, Richard Weinshilboum, Judith Weisz The involvement of estrogens in carcinogenic processes within estrogen-responsive
More information